Gökmen Aktaş

641 total citations
37 papers, 406 citations indexed

About

Gökmen Aktaş is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Gökmen Aktaş has authored 37 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Gökmen Aktaş's work include Cancer Treatment and Pharmacology (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Gökmen Aktaş is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Gökmen Aktaş collaborates with scholars based in Türkiye, Cyprus and Germany. Gökmen Aktaş's co-authors include Tülay Kuş, Celaletdin Camcı, Mehmet Kalender, Alper Sevinç, Seval Kul, Benan Kılbaş, Steffi Dreha‐Kulaczewski, Umut Elboğa, Jutta Gärtner and Klaus‐Dietmar Merboldt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Medicine.

In The Last Decade

Gökmen Aktaş

34 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gökmen Aktaş Türkiye 11 247 96 68 68 66 37 406
Tülay Kuş Türkiye 12 260 1.1× 133 1.4× 73 1.1× 77 1.1× 66 1.0× 47 416
Marià Carulla Spain 12 229 0.9× 64 0.7× 95 1.4× 59 0.9× 38 0.6× 29 490
Shin-ichi Yamashita Japan 15 149 0.6× 108 1.1× 165 2.4× 100 1.5× 41 0.6× 31 553
Alfredo Löhr Brazil 11 159 0.6× 82 0.9× 34 0.5× 132 1.9× 25 0.4× 26 471
Munveer S. Bhangoo United States 12 162 0.7× 55 0.6× 164 2.4× 110 1.6× 35 0.5× 27 563
Hiroshi Ogawa Japan 12 177 0.7× 206 2.1× 107 1.6× 29 0.4× 118 1.8× 45 525
Lance T. Hall United States 15 79 0.3× 68 0.7× 110 1.6× 28 0.4× 250 3.8× 34 624
Katarzyna Ziemnicka Poland 20 168 0.7× 159 1.7× 51 0.8× 49 0.7× 72 1.1× 89 972
Ana Isabel Enríquez Rodríguez Spain 9 105 0.4× 35 0.4× 32 0.5× 30 0.4× 16 0.2× 27 430
Lise Tremblay Canada 16 290 1.2× 46 0.5× 240 3.5× 73 1.1× 92 1.4× 33 857

Countries citing papers authored by Gökmen Aktaş

Since Specialization
Citations

This map shows the geographic impact of Gökmen Aktaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gökmen Aktaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gökmen Aktaş more than expected).

Fields of papers citing papers by Gökmen Aktaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gökmen Aktaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gökmen Aktaş. The network helps show where Gökmen Aktaş may publish in the future.

Co-authorship network of co-authors of Gökmen Aktaş

This figure shows the co-authorship network connecting the top 25 collaborators of Gökmen Aktaş. A scholar is included among the top collaborators of Gökmen Aktaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gökmen Aktaş. Gökmen Aktaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aktaş, Gökmen, et al.. (2024). Clinicopathological importance of immunohistochemical expression of OCT4, c-MYC and Ki-67 in colorectal cancer. Polish Journal of Pathology. 75(4). 333–342. 1 indexed citations
2.
3.
Kuş, Tülay, Gökmen Aktaş, & İrfan Çiçin. (2023). Is the “P-value” Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?. The Oncologist. 29(3). 190–191. 1 indexed citations
4.
Kuş, Tülay, et al.. (2022). The predictive value of vitamin D follow-up and supplementation on recurrence in patients with colorectal cancer. Future Oncology. 18(18). 2247–2256. 1 indexed citations
5.
Sever, Özlem Nuray, et al.. (2022). CLINICAL FACTORS PREDICTING RESPONSE TO REGORAFENIB IN METASTATIC COLORECTAL CANCER. 9(20). 23–27. 1 indexed citations
6.
Elboğa, Umut, Ertan Şahin, Gökmen Aktaş, et al.. (2022). Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience. Tomography. 8(1). 293–302. 18 indexed citations
7.
Elboğa, Umut, Ertan Şahin, Tülay Kuş, et al.. (2022). Comparison of 68Ga-FAPI PET/CT and 18FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement. Molecular Imaging and Biology. 24(5). 789–797. 30 indexed citations
8.
İşbilen, Elif, et al.. (2021). Better survival associated with successful vitamin D supplementation in non-metastatic breast cancer survivors. Turkish Journal of Biochemistry. 46(5). 509–516. 2 indexed citations
9.
Elboğa, Umut, Ertan Şahin, Tülay Kuş, et al.. (2021). Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer. Annals of Nuclear Medicine. 35(12). 1321–1331. 72 indexed citations
10.
Koca, Tuba Tülay, et al.. (2020). Prevelance of upper extremity lymphedema and risk factors in patients with mastectomy: Single-center, observational, cross-sectional study. Journal of Turkish Society of Obstetric and Gynecology. 17(3). 215–224. 5 indexed citations
11.
Kuş, Tülay, Fatih Köse, Gökmen Aktaş, et al.. (2020). Prediction of Peritoneal Recurrence in Patients with Gastric Cancer: a Multicenter Study. Journal of Gastrointestinal Cancer. 52(2). 634–642. 10 indexed citations
12.
Kuş, Tülay, et al.. (2019). Hepatosteatosis may predict late recurrence of breast cancer: A single-center observational study. Current Problems in Cancer. 43(6). 100461–100461. 2 indexed citations
13.
Kuş, Tülay & Gökmen Aktaş. (2017). Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer survival. SHILAP Revista de lepidopterología. 43(3). 273–278. 4 indexed citations
14.
15.
Süner, Ali, Hakan Büyükhatipoğlu, Gökmen Aktaş, et al.. (2016). Polymorphisms in the <em>MTHFR</em> gene are associated with recurrence risk in lymph node-positive breast cancer patients. OncoTargets and Therapy. Volume 9. 5603–5609. 1 indexed citations
16.
Bülbül, Feridun, et al.. (2016). Awareness of cancer diagnosis in Turkish patients can increase anxiety and depression: is it true?. Annals of Oncology. 27. vi520–vi520. 1 indexed citations
17.
18.
19.
Kuş, Tülay, Gökmen Aktaş, Gökay Alpak, et al.. (2015). Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case–control study. Supportive Care in Cancer. 24(5). 2085–2091. 17 indexed citations
20.
Kuş, Tülay, et al.. (2015). Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?. OncoTargets and Therapy. 8. 1341–1341. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tülay Kuş Breakdown of academic impact, for papers by Marià Carulla Breakdown of academic impact, for papers by Shin-ichi Yamashita Breakdown of academic impact, for papers by Alfredo Löhr Breakdown of academic impact, for papers by Munveer S. Bhangoo Breakdown of academic impact, for papers by Hiroshi Ogawa Breakdown of academic impact, for papers by Lance T. Hall Breakdown of academic impact, for papers by Katarzyna Ziemnicka Breakdown of academic impact, for papers by Ana Isabel Enríquez Rodríguez Breakdown of academic impact, for papers by Lise Tremblay
Rankless by CCL
2026